Goldman Sachs
June 9, 2026
Mettler-Toledo International Inc. Key Takeaways
EquitiesHealth CareIndustrials
Goldman Sachs remains Neutral on Mettler-Toledo, highlighting growth in pharma lab automation and robust industrial demand in China as key counterbalances to broader macro/industrial headwinds.
Key Takeaways
- 1.Mettler-Toledo is navigating industrial market uncertainty through solid demand momentum in China, particularly in automation, lithium-ion battery, and energy market investments.
- 2.Pharma customers represent a key growth driver, with demand fueled by lab automation needs, integration of AI, and stringent regulatory compliance in drug development.
Table of Contents
- Key Takeaways
- Valuation/Risks
- GS Forecast
- Disclosure Appendix
Document Preview
Access the Full Report
Get unlimited access to institutional research reports with a 14-day free trial.
Authors
Evie KosloskyGrey Smith
Securities
MTD
Themes
Laboratory AutomationArtificial Intelligence in PharmaChina Industrial Growth
Regions
Asia PacificEuropeUnited StatesChina
